The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers

British Journal of Cancer

Volumn 109, Issue 5, 2013, Pages 1344-1351

  Lai, G Y ^a   Weinstein, S J ^a   Albanes, D ^a   Taylor, P R ^a   McGlynn, K A ^a   Virtamo, J ^b   Sinha, R ^a   Freedman, N D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

liver cancer; chronic liver disease; coffee preparation; filtered coffee; boiled coffee; prospective cohort

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHRONIC LIVER DISEASE; COFFEE; COHORT ANALYSIS; CONTROLLED STUDY; FLUID INTAKE; FOLLOW UP; GROUPS BY AGE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AGED; CHRONIC DISEASE; COFFEE; FOOD HABITS; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING;

EID: 84883742887     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.405     Document Type: Article

References (54)

1. Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N, Hilding A, Ostenson CG (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255(6): 645-652. (Pubitemid 38703583)
2. Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J, Albanes D (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11): 2814-2821.
3. Altamirano J, Bataller R (2010) Cigarette smoking and chronic liver diseases. Gut 59(9): 1159-1162.
4. Arnesen E, Huseby NE, Brenn T, Try K (1986) The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 46(1): 63-70. (Pubitemid 16105277)
5. Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46(2): 430-435. (Pubitemid 47344778)
6. Bravi F, Bosetti C, Tavani A, La Vecchia C (2009) Coffee drinking and hepatocellular carcinoma: an update. Hepatology 50(4): 1317-1318.
7. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40(8): 1155-1163. (Pubitemid 34626880)
8. Cavin C, Holzhauser D, Constable A, Huggett AC, Schilter B (1998) The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 19(8): 1369-1375. (Pubitemid 28409833)
9. Chuang SC, La Vecchia C, Boffetta P (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer letters 286(1): 9-14.
10. Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L (1997) Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med 157(7): 792-796. (Pubitemid 27164455)
11. El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4(3): 369-380. (Pubitemid 43343895)
12. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7): 2557-2576. (Pubitemid 46890874)
13. Fan JG, Farrell GC (2009) Prevention of hepatocellular carcinoma in nonviralrelated liver diseases. J Gastroenterol Hepatol 24(5): 712-719.
14. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917.
15. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R (2009) Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50(5): 1360-1369.
16. Gross G, Jaccaud E, Huggett AC (1997) Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 35(6): 547-554. (Pubitemid 27273775)
17. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, Jousilahti P (2008) Joint effects of coffee consumption and serum gammaglutamyltransferase on the risk of liver cancer. Hepatology 48(1): 129-136. (Pubitemid 351975538)
18. Huber WW, Prustomersky S, Delbanco E, Uhl M, Scharf G, Turesky RJ, Thier R, Schulte-Hermann R (2002a) Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol. Arch Toxicol 76(4): 209-217. (Pubitemid 34591655)
19. Huber WW, Scharf G, Rossmanith W, Prustomersky S, Grasl-Kraupp B, Peter B, Turesky RJ, Schulte-Hermann R (2002b) The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 75(11-12): 685-694. (Pubitemid 34151155)
20. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169(22): 2053-2063.
21. Iwai K, Kishimoto N, Kakino Y, Mochida K, Fujita T (2004) In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. J Agric Food Chem 52(15): 4893-4898.
22. Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ (2001) Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Eepidemiol 153(4): 353-362. (Pubitemid 32144561)
23. Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM (2011) Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 22(3): 503-510.
24. Kitahara CM, Berrington de Gonzalez A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM (2011) Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29(12): 1592-1598.
25. Klatsky AL, Morton C, Udaltsova N, Friedman GD (2006) Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166(11): 1190-1195. (Pubitemid 43877627)
26. Kono S, Shinchi K, Imanishi K, Todoroki I, Hatsuse K (1994) Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am J Epidemiol 139(7): 723-727. (Pubitemid 24121281)
27. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncologica (Stockholm, Sweden) 41(4): 381-388.
28. Larsson SC, Wolk A (2007) Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 132(5): 1740-1745. (Pubitemid 46677953)
29. Majer BJ, Hofer E, Cavin C, Lhoste E, Uhl M, Glatt HR, Meinl W, Knasmuller S (2005) Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N- nitrosodimethylamine in a human derived liver cell line (HepG2). Food Chem Toxicol 43(3): 433-441. (Pubitemid 40170476)
30. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni Jr JF (2001) International trends and patterns of primary liver cancer. Int J Cancer 94(2): 290-296. (Pubitemid 32911426)
31. Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH (2010) Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 51(1): 201-209.
32. Muriel P, Arauz J (2010) Coffee and liver diseases. Fitoterapia 81(5): 297-305.
33. Nakanishi N, Nakamura K, Suzuki K, Tatara K (2000) Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers. Ind Health 38(1): 99-102. (Pubitemid 30091138)
34. Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertension 23(5): 921-928. (Pubitemid 40637906)
35. Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A (2006) Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes/Metabolism Res Rev 22(4): 274-283. (Pubitemid 44070503)
36. Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128(3): 655-666.
37. Poikolainen K, Vartiainen E (1997) Determinants of gammaglutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 146(12): 1019-1024. (Pubitemid 28030419)
38. Ratnayake WM, Hollywood R, O'Grady E, Stavric B (1993) Lipid content and composition of coffee brews prepared by different methods. Food Chem Toxicol 31(4): 263-269. (Pubitemid 23122367)
39. Ruhl CE, Everhart JE (2005) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128(1): 24-32. (Pubitemid 40039955)
40. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V (1998) Physiological insulinemia acutely modulates plasma leptin. Diabetes 47(4): 544-549. (Pubitemid 28160443)
41. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, Hu FB (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140(1): 1-8.
42. Sato Y, Itagaki S, Kurokawa T, Ogura J, Kobayashi M, Hirano T, Sugawara M, Iseki K (2011) In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int J Pharmaceutics 403(1-2): 136-138.
43. Shi H, Dong L, Jiang J, Zhao J, Zhao G, Dang X, Lu X, Jia M (2013) Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303: 107-114.
44. Siegel AB, Zhu AX (2009) Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 115(24): 5651-5661.
45. Souza MR, Diniz Mde F, Medeiros-Filho JE, Araujo MS (2012) Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arquivos De Gastroenterologia 49(1): 89-96.
46. Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H (1998) Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 27(3): 438-443. (Pubitemid 28336971)
47. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4(1): 1-10.
48. Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33(6): 1290-1300.
49. Tverdal A, Skurtveit S (2003) Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 13(6): 419-423. (Pubitemid 36870809)
50. Urgert R, Vanderweg G, Kosmeijerschuil TG, Vandebovenkamp P, Hovenier R, Katan MB (1995) Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agr Food Chem 43(8): 2167-2172.
51. van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2004) Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 47(12): 2152-2159. (Pubitemid 40174688)
52. Yamaji T,Mizoue T, Tabata S, Ogawa S, Yamaguchi K, Shimizu E, Mineshita M, Kono S (2004) Coffee consumption and glucose tolerance status in middle-aged Japanese men. Diabetologia 47(12): 2145-2151. (Pubitemid 40174687)
53. Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11: 96.
54. Yun N, Kang JW, Lee SM (2012) Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biochem 23(10): 1249-1255.